Literature DB >> 19116169

Chaperone-assisted production of active human Rab8A GTPase in Escherichia coli.

Nathalie Bleimling1, Kirill Alexandrov, Roger Goody, Aymelt Itzen.   

Abstract

The guanine nucleotide binding protein Rab8A controls the final steps of exocytosis in mammalian cells. It has been implicated in the regulation of apical protein localization in intestinal epithelial cells and ciliary biogenesis. The in vitro structural and biochemical characterization of Rab8A and its interaction with regulator and effector molecules has been hampered by its insolubility in Escherichia coli expression systems. The conventional refolding procedure is laborious and yields only minute amounts of C-terminally truncated Rab8A (Rab8A(1-183): amino acids 1-183), not the full-length protein. Here, we report a method of expressing soluble, hexahistidine-tagged full-length human Rab8A from E. coli. The Rab8A gene was codon-optimized and coexpressed with bacterial GroEL and GroES chaperones. After two-step purification by Ni(2+) affinity chromatography and gel filtration, Rab8A was obtained at a yield of 4 mg protein per 1L of bacterial cell culture and a purity of >95%. The resultant protein was functionally active, as determined by GTPase activity and its interaction with the nucleotide exchange factor MSS4.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19116169     DOI: 10.1016/j.pep.2008.12.002

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  10 in total

1.  Intermediates in the guanine nucleotide exchange reaction of Rab8 protein catalyzed by guanine nucleotide exchange factors Rabin8 and GRAB.

Authors:  Zhong Guo; Xiaomin Hou; Roger S Goody; Aymelt Itzen
Journal:  J Biol Chem       Date:  2013-09-26       Impact factor: 5.157

2.  A structural basis for Lowe syndrome caused by mutations in the Rab-binding domain of OCRL1.

Authors:  Xiaomin Hou; Nina Hagemann; Stefan Schoebel; Wulf Blankenfeldt; Roger S Goody; Kai S Erdmann; Aymelt Itzen
Journal:  EMBO J       Date:  2011-03-04       Impact factor: 11.598

3.  Posttranslational modifications of Rab proteins cause effective displacement of GDP dissociation inhibitor.

Authors:  Lena K Oesterlin; Roger S Goody; Aymelt Itzen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

4.  Human MICAL1: Activation by the small GTPase Rab8 and small-angle X-ray scattering studies on the oligomerization state of MICAL1 and its complex with Rab8.

Authors:  Alessandro Esposito; Valeria Ventura; Maxim V Petoukhov; Amrita Rai; Dmitri I Svergun; Maria A Vanoni
Journal:  Protein Sci       Date:  2018-10-31       Impact factor: 6.725

5.  EPI64 interacts with Slp1/JFC1 to coordinate Rab8a and Arf6 membrane trafficking.

Authors:  David E Hokanson; Anthony P Bretscher
Journal:  Mol Biol Cell       Date:  2012-01-04       Impact factor: 4.138

6.  Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1.

Authors:  Yu-Chiang Lai; Chandana Kondapalli; Ronny Lehneck; James B Procter; Brian D Dill; Helen I Woodroof; Robert Gourlay; Mark Peggie; Thomas J Macartney; Olga Corti; Jean-Christophe Corvol; David G Campbell; Aymelt Itzen; Matthias Trost; Miratul Mk Muqit
Journal:  EMBO J       Date:  2015-10-15       Impact factor: 11.598

7.  bMERB domains are bivalent Rab8 family effectors evolved by gene duplication.

Authors:  Amrita Rai; Anastasia Oprisko; Jeremy Campos; Yangxue Fu; Timon Friese; Aymelt Itzen; Roger S Goody; Emerich Mihai Gazdag; Matthias P Müller
Journal:  Elife       Date:  2016-08-23       Impact factor: 8.140

8.  Orthogonal ring-closing alkyne and olefin metathesis for the synthesis of small GTPase-targeting bicyclic peptides.

Authors:  Philipp M Cromm; Sebastian Schaubach; Jochen Spiegel; Alois Fürstner; Tom N Grossmann; Herbert Waldmann
Journal:  Nat Commun       Date:  2016-04-14       Impact factor: 14.919

9.  Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases.

Authors:  Martin Steger; Francesca Tonelli; Genta Ito; Paul Davies; Matthias Trost; Melanie Vetter; Stefanie Wachter; Esben Lorentzen; Graham Duddy; Stephen Wilson; Marco As Baptista; Brian K Fiske; Matthew J Fell; John A Morrow; Alastair D Reith; Dario R Alessi; Matthias Mann
Journal:  Elife       Date:  2016-01-29       Impact factor: 8.140

10.  The Loss of Expression of a Single Type 3 Effector (CT622) Strongly Reduces Chlamydia trachomatis Infectivity and Growth.

Authors:  Mathilde M Cossé; Michael L Barta; Derek J Fisher; Lena K Oesterlin; Béatrice Niragire; Stéphanie Perrinet; Gaël A Millot; P Scott Hefty; Agathe Subtil
Journal:  Front Cell Infect Microbiol       Date:  2018-05-15       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.